The 2025 Drug Sales Ranking Is a Commercial Disruption Map Keytruda held the top spot at $31.7 billion. Mounjaro came in second at $23 billion. Humira, once the world’s best-selling drug at $21 billion, closed 2025 at $4.5 billion. Most people read this ranking as a sales leaderboard. Our team at AIxBiotech reads it as […]
The 2025 Drug Sales Ranking Is a Commercial Disruption Map Read More »
On March 31 2026, Biogen acquired Apellis for $5.6B and Eli Lilly acquired Centessa for up to $7.8B on the same day. Both deals target mid-stage assets and include contingent value rights. For biotech operators this signals accelerating pipeline pressure and shrinking commercial planning windows.
$12 Billion in One Day: What Biogen and Lilly Deals Signal Read More »
TechCrunch reported that Harvey acquired Hexus on 2026-01-23.
The report described intensifying competition in legal tech.
Biotech legal teams: Harvey’s acquisition is a real signal Read More »
Unitree held a boxing match between two G1 humanoid robots at the BattleBots Arena during CES 2026.
The robots wore headgear and gloves, fought under a human referee, and were reported to cost about $13,500 each.
Unitree stages G1 humanoid robot boxing match at CES Read More »
University of Illinois researchers introduced Stomata In-Sight to observe stomata opening and closing in real time.
The system measures carbon dioxide and water vapor flow through leaves while imaging stomata.
Stomata In-Sight watches leaf pores breathe in real time Read More »
